Skip to main content
. 2019 May 3;33(3):855–862. doi: 10.21873/invivo.11550

Figure 1. Risk of bleeding after dental surgery in patients treated with vitamin K antagonist (VKA), low-molecular-weight heparin (LMWH) bridging, antiplatelet therapy, or direct oral anticoagulant (DOAC) as rated by study participants. Risk scale: +: low, ++: moderate, +++: high, ++++: extremely high.

Figure 1